Submitted by kBLASTER Team on
by BRAD PERRIELLO for MassDevice.com
Edap (NSDQ:EDAP) said today that it won 510(k) clearance from the FDA for its Ablatherm, less than a month after a similar device from rival SonaCare won a nod from the federal safety watchdog.
The Ablatherm device, like SonaCare’s Sonablate 450, is designed to ablate prostate tissue using high-intensity focused ultrasound. After a years-long dance with the FDA that saw it move from a pre-market approval application to a de novo bid, Edap applied for 510(k) clearance after the agency cleared the Sonablate 450 in October.
Today the Lyon, France-based company said it expects to begin marketing the device in the U.S. immediately.
“This is a tremendous achievement for the company and the result of many years of hard work from our team. This clearance represents a unique opportunity for Edap and its superior HIFU technology to penetrate the largest prostate market in the world in the same way it has emerged as the leading HIFU technology in Europe. With an established U.S. sales and services infrastructure, the pieces are in place to begin deploying Ablatherm devices in the U.S. very quickly and we look forward to bringing the technology to urologists as well as patients in need,” CEO Marc Oczachowski said in prepared remarks.
With nearly 62,000 510(k) summaries to search, including more than 76,000 splash pages (more than 138,000 records total), quickly find your primary predicate, multiple predicates or reference devices with kBLASTER. Save time with kBLASTER's effective result management features of sorting, My Favorites, Saved Search and Search History from a web browser, so mobile devices or computers can be used interchangeably to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spending by enabling self-service extraction of actionable insight from FDA medical device 510(k) clearance summaries.